Apellis Pharmaceuticals: Looking For Entry Around Crucial Q3 Earnings (NASDAQ:APLS)
By Press Room
6 Mins read
Apellis Pharmaceuticals (NASDAQ:APLS), a standout player in the biotech sector, distinguishes itself with its novel C3 inhibitor technology, including their flagship compound,…
Sarah was my childhood neighbour. Our mothers were best friends. They were both whimsical and free, and beautiful, but rolled their eyes…
Intel shares were gaining early on Friday. Analysts were upbeat about the chip maker’s results but expressed cautious confidence in both its…
Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say
By Press Room
1 Mins read
Diabetes-device makers’ stocks are breaking out of ‘GLP-1 jail’ ahead of schedule, analysts say, after months of stock-market punishment based on fears…
Earnings call: Dexcom reports strong Q3 2023 results, reveals plans for new product launch
By Press Room
2 Mins read
© Reuters. DexCom (NASDAQ:DXCM), a leading player in continuous glucose monitoring (CGM) technology, reported robust third-quarter results for 2023. The company’s organic…
When you see headlines about the private-equity industry or the people who run its funds and firms, you might think the news…
Investing.com – Oil ended one of its most volatile weeks for the year with a 3% loss as traders raced from one…
Is this a new bear market, and if so, how can investors adapt? Is this still a bull market, and investors should…
The benchmark S&P 500 index closed in correction territory on Friday, ending a week made volatile by weaker-than-expected earnings reports and strong…
Source: AdobeStock / photo_gonzo Kraken appoints Bivu Das, an ex-Starling Bank executive, as a UK corporate representative to drive business expansion in…